Statistics in the Service of Quality
Ensuring compliance though increased statistical knowledge and resources.
The Pediatric Challenge
Can microdosing make medicines safer and more effective for children?
Next-Gen Expression Systems
More sophisticated biological expression systems expand the functionality of the traditional systems for protein synthesis.
A Comparison of Three Extrusion Systems (Part II)
The authors compare three systems of single-screw extrusion using binary formulations for their suitability for producing pellets of various formulations and under various spheronization conditions.
Following our Own Instructions
Why SOPs are rarely followed, often cited, and in need of follow-through.
21st Century Innovation
Academic–industry partnerships are increasingly important in biopharmaceutical innovation.
In the Spotlight June 2011
Editor's picks of new manufacturing products for June 2011.
Global Healthcare on the Ground: BIO and BIO Ventures for Global Health
A Focus on Creative Strategies to Help the Developing World.
Wanted: Better Upstream Bioprocessing Technologies
A recent industry survey shows keen interest in improving bioreactors and cell-culture media.
Inhibiting the Precipitation of Poorly Water-Soluble Drugs from Labrasol Formulations
The study results suggested that Pluronic F127 might be a potent inhibitor of drug precipitation for Labrasol formulations.
Safety Concerns and Shortages Challenge Pharma
Industry struggles to curb drug abuse, diversion, and disruptions in supply.
Quality Overload
Sometimes, there are just too many cooks in the kitchen.
Prevention of Microbial Contamination
A holistic approach to establishing robust control measures.
Advocating for Biosimilar Approval Standards Under BPCI
FDA weighs multiple views regarding the Biologics Price Competition and Innovation Act.
The Means to Monitor Chemical Migration
Industry associations will soon provide new recommendations about extractables and leachables.
Q&A with Christopher Meissner, Meissner
Christopher Meissner, CEO of Meissner Filtration Products, on recent industry trends.
Policy and Leadership
This month's BIO Convention will encourage needed conversations.
Report from India
India's drug pricing authority increased the retail costs of certain domestically manufactured drugs, but not those of imported drug products. Pharma is asking why.
Optimizing High-Potency Manufacturing
Effective containment in API and drug-product manufacturing encompasses a variety of process, equipment, and operational issues.
Pharmaceutical Technology, June 2011 Issue (PDF)
